R. Skoda-Földes

  • Hungary

  • 1612 Citations
  • 19 h-Index
1989 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where R. Skoda-Földes is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 44 Similar Profiles
Palladium Chemical Compounds
Carbonylation Chemical Compounds
Ionic Liquids Chemical Compounds
Derivatives Chemical Compounds
Catalysts Chemical Compounds
phosphine Chemical Compounds
Steroids Chemical Compounds
Nucleophiles Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2019

  • 1612 Citations
  • 19 h-Index
  • 87 Article
  • 4 Chapter

Molecular Recognition of Strong Acids by Using a 2-Ureido-4-Ferrocenyl Pyrimidine Receptor

Keszei, S. J., Balogh, S., Fehér, C., Nagy, L., Tumanov, N., Wouters, J., Lendvay, G. & Skoda-Földes, R., Oct 17 2019, In : European Journal of Inorganic Chemistry. 2019, 38, p. 4095-4104 10 p.

Research output: Contribution to journalArticle

Molecular recognition
Nuclear magnetic resonance
Trifluoroacetic Acid
6 Citations (Scopus)

Carboxamido steroids inhibit the opening properties of transient receptor potential ion channels by lipid raft modulation

Sághy, É., Payrits, M., Bíró-Sütő, T., Skoda-Földes, R., Szánti-Pintér, E., Erostyák, J., Makkai, G., Sétáló, G., Kollár, L., Kőszegi, T., Csepregi, R., Szolcsányi, J., Helyes, Z. & Szöke, E., Jan 1 2018, In : Journal of Lipid Research. 59, 10, p. 1851-1863 13 p.

Research output: Contribution to journalArticle

Transient Receptor Potential Channels
Ion Channels
Chemical activation
1 Citation (Scopus)

Chapter 4: Carbonylation Reactions in the Synthesis of Pharmaceutically Active Compounds

Skoda-Földes, R. & Kollár, L., Jan 1 2018, Catalyst-free Organic Synthesis. 54 ed. Royal Society of Chemistry, p. 40-65 26 p. (RSC Green Chemistry; vol. 2018-January, no. 54).

Research output: Chapter in Book/Report/Conference proceedingChapter

carbonyl compound
Drug products